Access to affordable healthcare, including fast access to new medicines through the Pharmaceutical Benefits Scheme (PBS), is the second most important priority for Australians behind cost of living, data from the latest Mood of the Nation survey by SEC Newgate shows.
The survey of 1,611 Australians found 68% believe the government should be investing more to ensure quality affordable healthcare for all Australians and rank it as the second most important priority behind reducing cost increases for household bills and other essential expenses.
Nearly three quarters of Australians (74%) believe the government should subside the best medicines available, even if it means more of a cost to taxpayers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze